(Q44323787)

English

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

2

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

object named as

Stefan Faderl

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Jorge Eduardo Cortes

1

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

10

object named as

Susan O'Brien

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8

object named as

Francis Giles

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Guillermo Garcia-Manero

7

object named as

Guillermo Garcia-Manero

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Michael Andreeff

9

object named as

Michael Andreeff

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Michael J. Keating

11

object named as

Michael Keating

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

3

object named as

Maher Albitar

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

12

object named as

Elihu Estey

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Deborah Thomas

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Charles Koller

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1234-1241

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Angiogenesis and angiogenic mediators in haematological malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

High pre-treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of daunorubicin in the induction therapy for adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomes as carriers of cancer chemotherapy. Current status and future prospects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of liposomal daunorubicin in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of untreated acute myeloid leukemia in the elderly: remission-induction using a non-cytarabine-containing regimen of mitoxantrone plus etoposide.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitoxantrone and etoposide: an effective regimen for refractory or relapsed acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of thalidomide in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinca alkaloids: anti-vascular effects in a murine tumour

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of angiogenesis by anthracyclines and titanocene dichloride.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11180

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.11180

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

release_i7fn24nhb5ekdjgfrmz44ra6o4

1 reference

https://api.fatcat.wiki/v0/release/i7fn24nhb5ekdjgfrmz44ra6o4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44323787&oldid=2109442911"